Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 4Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Metastatic gpNMB Expressing Triple Negative Breast Cancer 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Diseases 1Brain Neoplasms 1Advanced Breast Cancer (Female) 1

Interventions

glembatumumab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Metastatic gpNMB Expressing Triple Negative Breast Cancer × Breast × Clear all
NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

Celldex Therapeutics

No longer available
Breast

Metastatic gpNMB Expressing Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡